Effects of phyto-oestrogens on tissues

Nutrition Research Reviews

Volumn 12, Issue 1, 1999, Pages 75-116

  Anderson, John J B ^a   Anthony, Mary ^a   Messina, Mark ^a   Garner, Sanford C ^a  

^a IL   (United States)

Author keywords

Blood lipids; Bone; Cancer; Phyto oestrogens; Soyabean

Indexed keywords

COUMESTROL; DAIDZEIN; ESTRADIOL; ESTROGEN RECEPTOR; GENISTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOESTROGEN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; ATHEROSCLEROSIS; BONE MASS; BREAST CANCER; CANCER; CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; FOOD INTAKE; HUMAN; LIPID BLOOD LEVEL; NONHUMAN; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; PROSTATE CANCER; SOYBEAN;

EID: 0032817379     PISSN: 09544224     EISSN: None     Source Type: Journal    
DOI: 10.1079/095442299108728875     Document Type: Article

References (200)

1. Adlercreutz H, Markkanen H & Watanabe S (1993) Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342, 1209-1210.
2. Adlercreutz H & Mazur W (1997) Phyto-estrogens and western diseases. Annals of Medicine 29, 95-120.
3. Adlercreutz H, van der Wilt J, Kinzel J, Attalla H, Wähalä K, Mäkelä T, Hase T & Fotsis T (1995) Lignan and isoflavonoid conjugates in human urine. Journal of Steroid Biochemistry and Molecular Biology 52, 97-103.
4. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M & Fukami Y (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. Journal of Biological Chemistry 262, 5592-5595.
5. Anderson JJ, Ambrose WW & Garner SC (1995a) Orally dosed genistein from soy and prevention of cancerous bone in two ovariectomized rat models. Journal of Nutrition 125, 799S Abstr.
6. Anderson JJB, Ambrose WW & Garner SC (1998) Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proceedings of the Society for Experimental Biology and Medicine 217, 345-350.
7. Anderson JJB & Garner SC (1997) The effects of phyto-estrogens on bone. Nutrition Research 20, 220-224.
8. Anderson JJB & Miller CP (1998) Lower lifetime estrogen exposure among vegetarians as a possible risk factor for osteoporosis: a hypothesis. Vegetarian Nutrition 2, 4-12.
9. Anderson JJB, Thomsen K & Christiansen C (1987) High protein meals, insular hormones, and urinary calcium excretion in human subjects. In Osteoporosis 1987, pp. 240-245 [C Christiansen, JS Johnson and B Riis, editors]. Copenhagen, Denmark: Osteopress ApS.
10. Anderson JW, Johnstone BM & Cook-Newell ME (1995b) Meta-analysis of the effects of soy protein intake on serum lipids. New England Journal of Medicine 333, 276-282.
11. Anderson RL & Wolf WJ (1995) Compositional changes in trypsin inhibitors, phytic acid, saponins and isoflavones related to soybean processing. Journal of Nutrition 125, 581S-588S.
12. Anonymous (1977) Report of the American Institute of Nutrition ad hoc Committee on Standards for Nutritional Studies. Journal of Nutrition 107, 1340-1348.
13. Anthony MS & Clarkson TB (1998) Comparison of soy phyto-estrogens and conjugated equine oestrogens on atherosclerosis progression in postmenopausal monkeys. Circulation 97, 829 Abstr.
14. Anthony MS, Clarkson TB, Bullock BC & Wagner JD (1997) Soy protein versus soy phyto-estrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arteriosclerosis, Thrombosis and Vascular Biology 17, 2524-2531.
15. Anthony MS, Clarkson TB, Hughes CL, Morgan TM & Burke GL (1996) Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. Journal of Nutrition 126, 43-50.
16. Anthony MS, Clarkson TB & Williams JK (1998) Effect of soy isoflavones on atherosclerosis potential mechanisms. American Journal of Clinical Nutrition 68, 1390S-1393S.
17. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuyntzakis M, Guo P & Kukreja SC (1996) Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. Journal of Nutrition 126, 161-167.
18. Arnold SF, Collins BM, Robinson MK, Guillette LJ Jr & McLachlan JA (1996) Differential interaction of natural and synthetic oestrogens with extracellular binding proteins in a yeast oestrogen screen. Steroids 61, 642-646.
19. Arts J, Kuiper GGJM, Janssen JMMF, Gustafsson JÅ, Löwik CWGM, Pol HAP & Van Leeuwen JPTM (1997) Differential expression of estrogen receptors χ and β mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology 138, 5067-5070.
20. Asahi M, Yanagi S, Ohta S, Inazu T, Sakai K, Takeuchi F, Taniguchi T & Yamamura H (1992) Thrombin-induced human platelet aggregation is inhibited by protein-tyrosine kinase inhibitors, ST638 and genistein. FEBS Letters 309, 10-14.
21. Baggott JE, Ha T, Vaughn WH, Juliana MM, Hardin JM & Grubbs CJ (1990) Effect of miso (Japanese soybean paste) and NaCl on DMBA-induced rat mammary tumors. Nutrition and Cancer 14, 103-109.
22. Balmir F, Staack R, Jeffrey E, Berber-Jimenez MD, Wang L & Potter SM (1996) An extract of soya flour influences serum cholesterol and thyroid hormones in rats and hamsters. Journal of Nutrition 126, 3046-3053.
23. Barnes S, Grubbs C, Setchell KDR & Carlson J (1990) Soybeans inhibit mammary tumors in models of breast cancer. In Mutagens and Carcinogens in the Diet, pp. 239-253 [MW Pariza, H-U Aeschbacher, JS Felton and S Sato, editors]. New York, NY: Wiley Liss.
24. Baum JA, Teng H, Erdman JW, Weigel RM, Klein BP, Persky VW, Freels S, Surya P, Bakhit RM, Ramos E, Shay NF & Potter SM (1998) Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell LDL receptor mRNA in hypercholesterolemic postmenopausal women. American Journal of Clinical Nutrition 68, 545-551.
25. Bennetts HW, Underwood EJ & Shier FL (1946) A specific breeding problem of sheep on subterranean clover pastures in western Australia. Australian Veterinary Journal 22, 2-12.
26. Benten WPM, Lieberherr M, Giese G & Wunderlich F (1998) Estradiol binding to cell surface raises cytosolic free calcium in T cells. FEBS Letters 422, 349-353.
27. 2+ influx via non-genomic surface receptors in activated T cells. FEBS Letters 407, 211-214.
28. Benvenuti S, Tanini A, Fredianin U, Bianchi S, Masi L, Casano R, Bufalino L, Serio M & Brandi ML (1991) Effects of ipriflavone on a clonal osteoblastic line. Journal of Bone and Mineral Research 6, 987-996.
29. Blair HC, Jordan SE, Peterson TG & Barnes S (1996) Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. Journal of Cellular Biochemistry 61, 629-637.
30. Bodine PVN, Henderson RA, Green J, Aronow M, Owen T, Stein GS, Lian JB & Komm BS (1998) Estrogen receptor-α is developmentally regulated during osteoblast differentiation and contributes to selective responsiveness of gene expression. Endocrinology 139, 2048-2057.
31. Brown NM & Lamartiniere CA (1995) Xenoestrogens alter mammary gland differentiation and cell proliferation in the rat. Environmental Health Perspectives 103, 708-713.
32. Carroll KK (1975) Experimental evidence of dietary factors and hormone-dependent cancers. Cancer Research 35, 3374-3383.
33. Cassidy A, Bingham S & Setchell K (1995) Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. British Journal of Nutrition 74, 587-601.
34. Cassidy A, Bingham S & Setchell KDR (1994) Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. American Journal of Clinical Nutrition 60, 333-340.
35. Cecchini MG, Fleisch H & Mühlbauer RC (1997) Ipriflavone inhibits bone resorption in intact and ovariectomized rats. Calcified Tissue International 61, S9-S11.
36. Chemopreventive Branch and Agent Development Committee (1996) Clinical development plan, genistein. Journal of Cellular Biochemistry 265, 114-126.
37. Connolly JM, Liu X-H & Rose DP (1997) Effects of dietary menhaden oil, soy, and a cyclooxygenase inhibitor on human breast cancer cell growth and metastasis in nude mice. Nutrition and Cancer 29, 48-54.
38. Constantinou A, Kiguchi K & Huberman E (1990) Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Research 50, 2618-2624.
39. Constantinou AL, Mehta RG & Vaughan A (1996) Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Research 16, 3293-3298.
40. Coward L, Barnes NC, Setchell KDR & Barnes S (1993) Genistein, daidzein, and their α-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets. Journal of Agricultural and Food Chemistry 41, 1961-1967.
41. Cowley SM, Hoare S, Mosselman S & Parker MG (1997) Estrogen receptors alpha and beta form heterodimers on DNA. Journal of Biological Chemistry 272, 19858-19862.
42. Crouse JR, Terry JG, Morgan TM, McGill BL, Davis DH, King T, Ellis JE & Burke GL (1998) Soy protein containing isoflavones reduces plasma concentrations of lipids and lipoproteins. Circulation 97, 816 Abstr.
43. Dalu A, Haskell J & Lamartiniere CA (1996) Dietary genistein inhibits protein tyrosine phosphorylation in the dorsolateral prostate of the rat. Proceedings of the Second International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, p. 47. Abstr. no. 10.
44. Dees C, Foster JS, Ahamed S & Wimalensa J (1997) Dietary estrogens stimulate human breast cancer cells to enter the cell cycle. Environmental Health Perspectives 105, Suppl. 3, 633-636.
45. Dodge JA, Glasebrook AL, Magee DE, Phillips DL, Sato M, Short LL & Bryant HU (1996) Environmental estrogens: Effects of cholesterol lowering and bone in the ovariectomized rat. Journal of Steroid Biochemistry and Molecular Biology 59, 155-161.
46. Draper CR, Edel MJ, Dick IM, Randall AG, Martin GB & Prince RL (1997) Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. Journal of Nutrition 127, 1795-1799.
47. Duncan AM, Merz BE, Xu X, Underhill KEW, Phipps WR & Kurzer MS (1998) Soy isoflavones do not exert hormonal effects in premenopausal women. FASEB Journal 12, A568 Abstr. no. 3295.
48. Evans BAJ, Griffiths K & Morton MS (1995) Inhibition of 5α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. Journal of Endocrinology 147, 295-302.
49. Folman Y & Pope GS (1966) The interaction in the immature mouse of potent estrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. Journal of Endocrinology 34, 215-225.
50. Foth D & Cline JM (1998) Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. American Journal of Clinical Nutrition 68, 1413S-1417S.
51. Fotsis T, Pepper M, Adlercreutz H, Gleischmann G, Hase T, Montesano R & Schweigerer L (1993) Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proceedings of the National Academy of Sciences, USA 90, 2690-2694.
52. Franke AA, Custer LJ, Cerna CM & Narala KK (1994) Quantitation of phytoestrogens in legumes by HPLC. Journal of Agriculture and Food Chemistry 42, 1905-1913.
53. Fujio Y, Fumiko Y, Takahashi K & Shibata N (1993) Responses of smooth muscle cells to platelet-derived growth factor are inhibited by herbimycin-A tyrosine kinase inhibitor+. Biochemical and Biophysical Research Communications 195, 79-83.
54. Gaub MP, Bellard M, Scheuer I, Chambon P & Sasson-Corsi P (1990) Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex. Cell 63, 1267-1276.
55. Geller J, Sionit L, Partido C, Lingna L, Tan X, Youngkin T, Nachtsheim D & Hoffman RM (1998) Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture. The Prostate 34, 75-79.
56. Gennari C, Adami S, Agnusdei D, Bufalino L, Cervetti R, Crepaldi G, Di Marco C, Di Munno O, Fantasia L, Isaia GC, Mazzuoli GF, Ortolani S, Passeri M, Serni U & Vecchiet L (1997) Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass. Calcified Tissue International 61, S19-S22.
57. Geynet C, Millet C, Truong H & Baulier EE (1972) Estrogens and antiestrogens. Hormone antagonists. Gynecologic Investigations 3, 2-29.
58. Gotoh T, Yarnada K, Ito A, Yin H, Kataoka T & Dohi K (1998a) Chemoprevention of N-nitroso-N-methylurea-induced rat mammary cancer by miso and tamoxifen, alone and in combination. Japanese Journal of Cancer Research 89, 487-495.
59. Gotoh T, Yamada K, Yin H, Ito A, Kataoka T & Dohi K (1998b) Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A. Japanese Journal of Cancer Research 80, 137-142.
60. Graf E & Eaton JW (1993) Suppression of colonie cancer by dietary phytic acid. Nutrition and Cancer 19, 11-19.
61. Greenstein J, Kushi L, Zheng W, Fee R, Campbell D, Sellers T & Folsom A (1996) Risk of breast cancer associated with intake of specific foods and food groups. American Journal of Epidemiology 143, S36 Abstr. no. 141.
62. Gridley DS, Kettering JD, Slater JM & Nutter RL (1983) Modification of spontaneous mammary tumors in mice fed different sources of protein, fat, and carbohydrate. Cancer Letters 19, 133-146.
63. Haggins CJ, Martini MC, Slavin JL, Thomas W & Bancisak BB (1998) Soy supplementation does not affect hormone levels or menstrual cycle length in women with or without oral contraceptives. FASEB Journal 12, A568 Abstr. no. 3296.
64. Hawrylewicz EJ, Huang HH & Blair WH (1991) Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats. Journal of Nutrition 121, 1693-1698.
65. Helmeste DM & Tang SW (1995) Tyrosine kinase inhibitors regulate serotonin uptake in platelets. European Journal of Pharmacology 280, R5-R7.
66. Hendrich S, Xu X, Lu Z, Dickerson S, Cunnick JE & Murphy PA (1998) Human isoflavone bioavailability during seven days of soymilk feeding, and lack of isoflavone effect of natural killer cell activity. FASEB Journal 12, A874 Abstr. no. 5060.
67. Higashi K & Ogawara H (1994) Daidzein inhibits insulin- or insulin-growth factor-1-mediated signaling in cell cycle progression of Swiss 3T3 cells. Biochimica et Biophysica Acta 1221, 29-35.
68. Hirano T, Oka K & Akiba M (1989) Antiproliferative effects of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZR-75-1. Research Communications in Chemical Pathology and Pharmacology 64, 69-78.
69. Hirayama T (1979) Epidemiology of prostate cancer with special reference to the role of diet. National Cancer Institute Monograph 53, 149-155.
70. Hirayama T (1986) A large scale cohort study on cancer risks by diet - with special reference to the risk reducing effects of green-yellow vegetable consumption. In Diet, Nutrition and Cancer, pp. 41 -53 [Y Hayashi, M Nagao, T Sugimara, S Tokayama, L Tomatis, LW Wattenberg and GN Wagen, editors]. Utrecht, The Netherlands: Tokyo/VNU Science Press.
71. Hirohata T, Shigematsu T, Nomura AMY, Normua Y, Horie A & Hirohata I (1985) Occurrence of breast cancer in relation to diet and reproductive history: a case-control study in Fukuoka, Japan. National Cancer Institute Monographs 69, 187-190.
72. Hirose K, Tajima K, Hamajima N, Inoue M, Takezaki T, Kuroisha T, Yoshida M & Tokudome S (1985) A large-scale hospital-based case-control study of risk factors of breast cancers according to menopausal status. Japanese Journal of Cancer Research 86, 146-154.
73. Hodgson JM, Croft KD, Puddey IB, Mori TA & Beillin LJ (1996) Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation in serum. Journal of Nutritional Biochemistry 7, 664-669.
74. Hodgson JM, Puddey IB, Beillin LJ, Mori TA & Croft KD (1998) Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. Journal of Nutrition 128, 728-732.
75. Honoré EK, Williams JK, Anthony MS & Clarkson TB (1997) Soy isoflavones enhance vascular reactivity in atherosclerotic female macaques. Fertility and Sterility 67, 148-154.
76. Hsieh C-Y, Santell RC, Haslam SZ & Helferich WG (1998) Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Research 58, 3833-3838.
77. Hsueh AM & Park H-S (1990) Quality of dietary protein and chemical carcinogenesis in rats. International News: Fats Oils Related Materials 1, 303 Abstr.
78. Huff MW, Hamilton RMG & Carroll KK (1977) Plasma cholesterol levels in rabbits fed low fat, cholesterol-free, semipurified diets: Effects of dietary proteins, protein hydrolysates and amino acid mixtures. Atherosclerosis 28, 187-195.
79. Imoto M, Yamashita T, Sawa T, Kurasawa S, Naganawa H, Takeuchi T, Bao-quan Z & Umezawa K (1988) Inhibition of cellular phosphatidylinositol turnover by psi-tectorigenin. FEBS Letters 230, 43-46.
80. Ingram D, Sanders K, Kolybaba M & Lopez D (1997) Phytoestrogens and breast cancer - a case control study. Lancet 350, 990-994.
81. Jayo MJ, Anthony MS, Register TC, Rankin SE, Vest T & Clarkson TB (1996) Dietary soy isoflavones and bone loss: a study in ovariectomized monkeys. Journal of Bone and Mineral Research 11, Suppl. 1, S228 Abstr. S555.
82. Jing Y, Nakaya K & Han R (1993) Differentiation of promyelocytic leukemia cells HL-60 induced by daidzein in vitro and in vivo. Anticancer Research 13, 1049-1054.
83. Kamei H, Koide T, Hashimoto Y, Kojima T, Umeda T & Hasegawa M (1997) Tumor cell growth-inhibiting effects of melanoidins extracted from miso and soy sauce. Cancer Biotherapy & Radiopharmaceuticals 12, 405-409.
84. Kennedy AR & Manzone H (1995) Effects of protease inhibitors on levels of proteolytic activity in normal and premalignant cells and tissues. Journal of Cellular Biochemistry 22, Suppl., 188-194.
85. King RA & Bursill DB (1998) Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. American Journal of Clinical Nutrition 67, 867-872.
86. Kirk EA, Sutherland P, Wang SA, Chait A & LeBoeuf RC (1998) Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. Journal of Nutrition 128, 954-959.
87. Koratkar R & Rao AV (1997) Effect of soy bean saponins on azoxymethane-induced preneoplastic lesions in the colon of mice. Nutrition and Cancer 27, 206-209.
88. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S & Gustafsson JÅ (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138, 863-870.
89. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S & Gustafsson JÅ (1996) Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proceedings of the National Academy of Sciences, USA 93, 5925-5930.
90. Kuo S-M (1996) Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Letters 110, 41-48.
91. Kuruvilla A, Putcha G, Poulos E & Shearer WT (1993) Tyrosine phosphorylation of phospholipase C concomitant with its activation by platelet-activating factor in a human B cell line. Journal of Immunology 151, 637-648.
92. Kyle E, Neckers L, Takimoto C, Curt G & Bergan R (1997) Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Molecular Pharmacology 51, 193-200.
93. Lamartiniere CA, Moore JB, Brown NM, Thompson R, Hardin MJ & Barnes S (1995) Genistein suppresses mammary cancer in rats. Carcinogenesis 16, 2833-2840.
94. Le Mellay V, Grosse B & Lieberherr M (1997) Phospholipase C β and membrane action of calcitriol and estradiol. Journal of Biological Chemistry 272, 11902-11907.
95. Lee HP, Gourley L, Duffy SW, Esteve J & Day NE (1991) Dietary effects on breast-cancer risk in Singapore. Lancet 337, 1197-1200.
96. Lees C & Ginn TA (1998) Soy protein isolate diet does not prevent increased cortical bone turnover in ovariectomized macaques. Calcified Tissue International 62, 557-558.
97. Linassier C, Pierre M, Le Peco J-B & Pierre J (1990) Mechanism of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochemical Pharmacology 39, 187-193.
98. Lu L-J, Anderson KE, Grady JJ & Nagamani M (1996a) Effects of soy consumption for one month on steroid hormones in postmenopausal women: implications for breast cancer risk reduction. Cancer Epidemiology, Biomarkers and Prevention 5, 63-70.
99. Lu L-J, Anderson KE, Grady JJ & Nagamani M (1996b) Effects of one month soy consumption on circulating steroids in men. Proceedings of the American Association for Cancer Research 37, 270 Abstr. no. 1841.
100. Machelon V, Nomé F, Grosse B & Lieberherr M (1996) Progesterone triggers rapid transmembrane calcium influx and/or calcium mobilization from endoplasmic reticulum, via a pertussis-insensitive G-protein in granulosa cells in relation to luteinization process. Journal of Cellular Biochemistry 61, 619-628.
101. McMichael-Phillips DF, Harding C, Morton M, Roberts ST, Howell A, Potten CS & Bundred NJ (1998) The effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. American Journal of Clinical Nutrition 68, Suppl., 1431S-1436S.
102. McNicol A (1993) The effects of genistein on platelet function are due to thromboxane receptor antagonism rather than inhibition of tyrosine kinase. Prostaglandins, Leukotrienes and Essential Fatty Acids 48, 379-384.
103. Mäkelä S, Davis VL, Tally WC, Korkman J, Sala L, Vinko R & Korach KS (1994) Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environmental Health Perspectives 102, 572-578.
104. Mäkelä SI, Pylkkänen LH, Santti RSS & Adlercreutz H (1995) Dietary soybean may be antiestrogenic in male mice. Journal of Nutrition 125, 437-445.
105. Makishima M, Honma Y, Hozumi M, Nagata N & Motoyoshi K (1993) Differentiation of human monoblastic leukemia U837 cells induced by inhibitors of myosin light chain kinase and prevention of differentiation by granulocyte macrophage colony stimulating factor. Biochimica et Biophysica Acta 1176, 245-249.
106. Markiewicz L, Garey J, Adlercreutz H & Gurpide E (1993) In vitro bioassays of non-steroidal phytoestrogens. Journal of Steroid Biochemistry and Molecular Biology 45, 399-405.
107. Martin ME, Haourigui M, Pelissero C, Benassayag C & Nunez EA (1996) Interactions between phytoestrogens and human sex steroid binding protein. Life Sciences 58, 429-436.
108. Martin PM, Horwitz KB, Ryan DS & McGuire WL (1978) Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 103, 1860-1867.
109. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishimo H & Aoike A (1993) Genistein arrests cell cycle progression at G2-M. Cancer Research 53, 1328-1331.
110. Mayr U, Butsch A & Schneider S (1992) Validation of two in vitro test systems for estrogenic activities with zearalenone, phytoestrogens and cereal extracts. Toxicology 74, 135-149.
111. Meeker DR & Kesten HD (1941) Effect of high protein diets on experimental atherosclerosis of rabbits. Archives of Pathology 31, 147-162.
112. Menon LG, Kuttan R, Nair MG, Chang Y-C & Kuttan G (1998) Effect of isoflavones genistein and daidzein in the inhibition of lung; metastasis in mice induced by B16F-10 melanoma cells. Nutrition and Cancer 30, 74-77.
113. Messina M (1995) Isoflavone intakes by Japanese were overestimated (letter to the editor). American Journal of Clinical Nutrition 62, 645.
114. Messina M, Persky V, Setchell KDR & Barnes S (1994) Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutrition and Cancer 21, 113-131.
115. Messina MJ & Barnes S (1991) The role of soy products in reducing risk of cancer. Journal of the National Cancer Institute 83, 541-546.
116. Migliaccio S, Davis VL, Gibson MK, Gray TK & Korach KS (1992) Estrogens modulate the responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor. Endocrinology 130, 2617-2624.
117. Miksicek RJ (1993) Commonly occurring plant flavonoids have estrogenic activity. Molecular Pharmacology 44, 37-43.
118. Miksicek RJ (1994) Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. Journal of Steroid Biochemistry and Molecular Biology 49, 153-160.
119. Mitchell JH & Collins AR (1998) Effects of soy milk supplement on oxidative DNA damage in men: a pilot study. COST 916 Workshop, April 17-18. The Netherlands.
120. Moorghen M, Orde M, Finney KJ, Appleton DR & Watson AJ (1998) Sulindac enhances cell proliferation in DMH-treated mouse colonie mucosa. Cell Proliferation 31, 59-70.
121. Morton MS, Matos-Ferreira A, Abranches-Monteiro L, Correia R, Blacklock N, Chan PSF, Cheng C, Lloyd S, Chiehping W & Griffiths K (1997) Measurement and metabolism of isoflavonoids and lignans in human male. Cancer Letters 114, 145-151.
122. Murillo G, Singletary KW, Kamath SK & Arjmandi BH (1998) The antitumorigenic properties of ipriflavone and genistein in rat mammary tissues. FASEB Journal 12, A828 Abstr. no. 4801.
123. Murphy CT, Kellie S & Westwick J (1993) Tyrosine-kinase activity in rabbit platelets stimulated with platelet-activating factor. The effect of inhibiting tyrosine kinase with genistein on platelet-signal-molecule elevation and functional responses. European Journal of Biochemistry 216, 639-651.
124. Murrill WB, Brown NM, Zhang J-X, Manzolillo PA, Barnes S & Lamartiniere CA (1996) Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17, 1451-1457.
125. Nagata C, Takatsuka N, Kurisu Y & Shimizu H (1998) Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. Journal of Nutrition 128, 209-213.
126. Naik HR, Lehr JE & Pienta KJ (1994) An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer. Anticancer Research 14, 2617-2620.
127. 3: potential relation of a plasmalemmal receptor to the acute enhancement of intestinal calcium transport in chick. Journal of Nutrition 125, 1695S-1698S.
128. 3. Endocrinology 137, 2254-2261.
129. Nestel PJ, Yamashita T, Sasahara T, Pomeroy S, Dart A, Komesaroff P, Owen A & Abbey M (1997) Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterisclerosis, Thrombosis and Vascular Biology 17, 3392-3398.
130. Nomura A, Henderson BE & Lee J (1978) Breast cancer and diet among the Japanese in Hawaii. American Journal of Clinical Nutrition 31, 2025-2030.
131. Oishi K, Okada K, Yoshida O, Yamabe H, Ohno Y, Hayes RB & Schroeder FH (1988) A case control study of prostatic cancer with reference to dietary habits. Prostate 12, 179-190.
132. Okura A, Arakawa H, Oka H, Yoshinari T & Monden Y (1988) Effect of genistein on topoisomerase activity and the growth of val 12 H-ras-transformed NIH3T3 cells. Biochemical and Biophysical Research Communications 157, 183-189.
133. Olsson H, Landin-Olsson M & Gullberg B (1983) Retrospective assessment of menstrual cycle length in patients with breast cancer, in patients with benign breast disease, and in women without breast disease. Journal of the National Cancer Institute 70, 17-20.
134. Onoe Y, Miyaura C, Ohta H, Nozawa S & Suda T (1997) Expression of estrogen receptor β in rat bone. Endocrinology 138, 4509-4512.
135. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ & Scanlan TS (1997) Differential ligand activation of estrogen receptors ERalpha and ERbeta at API sites. Science 277, 1508-1510.
136. Pagliacci MC, Smacchia M, Migliorati G, Grignana F, Riccardi C & Nicoletti I (1994) Growth-inhibitory effects of the natural phytoestrogen genistein in MCF-7 human breast cancer cells. European Journal of Cancer 30A, 1675-1682.
137. Pansini F, Bonaccorsi G, Albertazzi P, Costantino D, Valerio A, Negri C, Ferrazzini S, Bonocuore I, De Aloysio D, Fontana A, Pansini N & Mollica G (1997) Soy phytoestrogens and bone. Annual Meeting of the North American Menopause Society, p. 44, Abstr. no. 97.061.
138. Peterson G & Barnes S (1991) Genistein inhibits of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochemical and Biophysical Research Communications 179, 661-667.
139. Peterson G & Barnes S (1993) Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor autophosphorylation. The Prostate 22, 335-345.
140. Peterson G & Barnes S (1996) Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth and Differentiation 7, 1345-1351.
141. Peterson TG, Kim H & Barnes S (1998) Genistein may inhibit the growth of human mammary epithelial (HME) cell by augmenting by transforming growth factor beta (TGFβ) signaling. American Journal of Clinical Nutrition 68, Suppl., 1527S-1528S.
142. Petrakis NL, Barnes S, King EB, Lowenstein J, Wiencke J, Lee MM, Miike R, Kirk M & Coward L (1996) Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention 5, 785-794.
143. Pettersson K, Grandien K, Kuiper GG & Gustafsson JA (1997) Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptors alpha. Molecular Endocrinology 11, 1486-1496.
144. Picotto G, Massheimer V & Boland R (1996) Acute stimulation of intestinal cell calcium influx induced by 17β-oestradiol via the cAMP messenger system. Molecular and Cellular Endocrinology 119, 129-134.
145. Pienta KJ & Esper PS (1993) Risk factors for prostate cancer. Annals of Internal Medicine 118, 793-803.
146. Pollard M & Luckert PH (1997) Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats. Nutrition and Cancer 28, 41-45.
147. Potter SM, Baum JA, Teng H, Stillman RJ & Erdman JW Jr (1998) Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women. American Journal of Clinical Nutrition 68, 1375S-1379S.
148. Potter SM, Jimenez-Flores R, Pollack J-A, Lone TA & Berber-Jiminez MD (1993) Protein-saponin interaction and its influence on blood lipids. Journal of Agricultural and Food Chemistry 41, 1287-1291.
149. Ramakrishna MBV, Mital BK, Gupta KC & Sand NK (1989) Determination of phenolic acids in different soybean varieties by reversed phase high performance liquid chromatography. Journal of Food Science and Technology 26, 154-155.
150. Rao AV & Janezic SA (1992) The role of dietary phytosterols in colon carcinogenesis. Nutrition and Cancer 18, 43-52.
151. Rauth S, Kichina J & Green A (1997) Inhibition of growth and induction of differentation of metastatic melanoma cells in vitro by genistein: chemosensitivity is regulated by cellular p53. British Journal of Cancer 75, 1559-1566.
152. Register TC, Anthony M, Jayo MJ & Williams JK (1997) Effects of 17β-oestradiol and consumption of phytoestrogen-rich soy or casein/lactalbumin-based diets on serum chemistries in ovariectomized female macaques. Journal of Bone and Mineral Research 12 Suppl. 1, S350 Abstr. no. F498.
153. Ross RK, Bernstein LA, Lobo RA, Shimizu H, Stanczyk FZ, Pike MC & Henderson BE (1992) 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and lack males. Lancet 339, 887-889.
154. Ruiz-Larrea MB, Mohan AR, Paganga G, Miller NJ, Bolwell GP & Rice-Evans CA (1997) Antioxidant activity of phytoestrogenic isoflavones. Free Radical Research 26, 63-70.
155. Santell RC, Chang YC, Nair MG & Helferich WG (1997) Dietary genistein exerts estrogen effects upon the uterus, mammary gland and the liypothalmic/pituitary axis in rats. Journal of Nutrition 127, 263-269.
156. Santell RC, Kieu N & Helferich WG (1998) The effect of genistein upon estrogen receptor negative human breast cancer cell growth in vitro and in vivo. FASEB Journal 12, A655 Abstr. no. 3807.
157. Santibáñez JF, Navarro A & Martinez J (1997) Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines. Anticancer Research 17, 1199-1204.
158. Sathyamoorthy N & Wang TTY (1997) Differential effects of dietary phytoestrogen daidzein and equol on human breast cancer MCF-7 cells. European Journal of Cancer 33, 2384-2389.
159. Schleicher T, Zheng M, Zhang M & Lamartiniere CA (1998) Genistein inhibition of prostate cancer cell growth and metastasis in vivo. American Journal of Clinical Nutrition 68, Suppl., 1526S Abstr.
160. Scholar EM & Toewa ML (1994) Inhibition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genistein. Cancer Letters 87, 159-162.
161. Severson KJ, Nomura AMY, Grove JS & Stemmermann GN (1989) A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Research 49, 1857-1860.
162. Shao Z-M, Alpaugh ML, Fontana JA & Barsky SH (1998) Genistein
163. Shibata A, Whittemore AS, Imai K, Kolonel LN, Wu AH, John EM, Stamey TA & Paggenbarger RS (1997) Serum levels of prostate specific antigen among Japanese-American and native Japanese men. Journal of the National Cancer Institute 89, 1716-1720.
164. Shimokado K, Umezawa K & Ogata J (1995) Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells. Experimental Cell Research 220, 266-273.
165. Shimokado K, Yokota T, Umezawa K, Sasaguri T & Ogata J (1994) Protein tyrosine kinase inhibitors chemotaxis of vascular smooth muscle cells. Arteriosclerosis and Thrombosis 14, 973-981.
166. Sonn TT, Hendrich S & Murphy PA (1997) Estrogenic activity of glycitein, a soy isoflavone. FASEB Journal 11, A601 Abstr. no. 3472.
167. Spinozzi F, Pagliacci MC, Migliorati G, Moraca R, Grionani F, Riccardi C & Nicoletti I (1994) The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. Leukemia Research 18, 431-439.
168. Stephens FO (1997) Phytoestrogens and prostate cancer: possible preventive role. Medical Journal of Australia 167, 138-140.
169. Sugano M & Koba K (1993) Dietary protein and lipid metabolism: a multifunctional effect. Annals of the New York Academy of Sciences 676, 215-222.
170. Thorburn J & Thorburn T (1994) The tyrosine kinase inhibitor, genistein, prevents α-adrenergic-induced cardiac muscle cell hypertrophy by inhibiting activation of the Ras-MAP kinase signalling pathway. Biochemical and Biophysical Research Communications 202, 1586-1591.
171. Tobe H, Komiyama O, Komiyama Y & Maruyama HB (1997) Daidzein stimulation of bone resorption in pit formation assay. Bioscience, Biotechnology and Biochemistry 61, 370-371.
172. Tovar-Palacio C, Potter SM, Hafermann JC & Shay NF (1998) Intake of soy protein and soy protein extracts influences lipid metabolism and hepatic gene expression in gerbils. Journal of Nutrition 128, 839-842.
173. Troll W, Wiesner R, Shellabarger CJ, Hotzman S & Stone JP (1980) Soybean diet lowers breast tumor incidence in irradiated rats. Carcinogenesis 1, 469-472.
174. Tsutsumi N (1995) Effect of coumestrol on bone metabolism in organ culture. Biological and Pharmaceutical Bulletin 18, 1012-1015.
175. Umayahara Y, Kawamori R, Watada H, Imano E, Iwama N, Morishima T, Yamasaki Y, Kajimoto Y & Kamada T (1994) Estrogen regulation of the insulin-like growth factor 1 gene transcription involves an AP-1 enhancer. Journal of Biological Chemistry 269, 16433-16442.
176. Wang H-j & Murphy PA (1994) Isoflavone content in commercial soybean foods. Journal of Agricultural and Food Chemistry 42, 1666-1673.
177. Wang TY, Sathyamoorthy N & Phang JM (1996) Molecular affects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17, 271-275.
178. Wang W, Higuchi CM & Zhang R (1997) Individual and combinatory effects of soy isoflavones on the in vitro potentiation of lymphocyte activation. Nutrition and Cancer 29, 29-34.
179. Wang Y, Heston DWD & Fair WB (1995) Soy isoflavones decrease the high-fat promoted growth of human prostate cancer. Results of in vivo and animal studies. Journal of Urology 153, Abstr. no. 161.
180. Watson CS, Pappas TC & Gametchu B (1995) The other estrogen receptor in the plasma membrane: implications for the actions of environmental estrogens. Environmental Health Perspectives 103, Suppl. 7, 41-50.
181. Wei H, Wei L, Frenkel K, Bowen R & Barnes S (1993) Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutrition and Cancer 20, 1-12.
182. Williams JP, Jordan SE, Barnes S & Blair HC (1998) Tyrosine kinase inhibitor effects on osteoclastic acid transport. American Journal of Clinical Nutrition 68, 1369S-1374S.
183. Weisz A & Rosales R (1990) Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Research 18, 5097-5106.
184. Witztum JL & Steinberg D (1991) Role of oxidized low density lipoprotein in atherogenesis. Journal of Clinical Investigation 88, 1785-1792.
185. Wrensch MR, Petrakis NL, King EB, Mike R, Mason L, Chew KL, Lee MM, Ernster VL, Hilton JF, Schweitzer R, Goodson WH, III & Hunt TK (1991) Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. American Journal of Epidemiology 135, 130-141.
186. Wu A & Pike MC (1995) Dietary soy protein and hormonal status. American Journal of Clinical Nutrition 62, 151-152.
187. Wu AH, Ziegler RG, Horn-Ross PL, Nomura AMY, West DW, Kolonel L, Rosenthal JF, Hoover RN & Pike MC (1996) Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiology, Biomarkers, and Prevention 5, 901-906.
188. Wu AH, Ziegler RG, Horn-Ross PL, Nomura AMY, West DW, Kolonel L, Rosenthal JF, Hoover RN & Pike MC (1998) Soy intake and risk of breast cancer in Asians and Asian Americans. American Journal of Clinical Nutrition 68, 1437S-1443S.
189. Xu X, Harris KS, Wang H-J, Murphy PA & Hendrich S (1995) Bioavailability of soybean isoflavones depends upon gut microflora in women. Journal of Nutrition 125, 2307-2315.
190. Xu X, Wang HJ, Murphy PA, Cook L & Hendrich S (1994) Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. Journal of Nutrition 124, 825-832.
191. Yan L, Yee JA, Li D & McGuire MH (1998) Effect of dietary supplementation of isoflavones on pulmonary metastasis of melanoma cells in mice. FEBS Journal 12, A829 Abstr. no. 4804.
192. Yan L, Yee JA, McGuire MH & Graef GL (1997) Effect of dietary supplementation of soybeans on experimental metastasis of melanoma cells in mice. Nutrition and Cancer 29, 1-8.
193. Yanighara K, Ito A, Toge T & Numoto M (1993) Antiproliferative effect of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Research 53, 5815-5821.
194. Yatani R, Kusano I, Shiraishi T, Hayashi T & Stemmerman GN (1989) Latent prostatic carcinoma: pathological and epidemiological aspects. Japanese Journal of Clinical Oncology 19, 319-326.
195. Yuan J-M, Wang Q-S, Ross RK, Henderson BE & Yu MC (1995) Diet and breast cancer in Shanghai and Tianjin, China. British Journal of Cancer 71, 1353-1358.
196. Yuan J-M, Yu MC, Ross RK, Gao Y-T & Henderson BE (1988) Risk factors for breast cancer in Chinese women in Shanghai. Cancer Research 48, 1949-1953.
197. Zava DT & Duwe G (1997) Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutrition and Cancer 27, 31-40.
198. Zhang JX, Hallmans G, Landstrom M, Bergh A, Damber J-E, Aman P & Adlercreutz H (1997a) Soy and rye diets inhibit the development of Dunning R3327 prostatic adenocarcinoma in rats. Cancer Letters 114, 313-314.
199. Zhang R, Li Y & Wang W (1997b) Enhancement of immune function in mice fed high doses of soy daidzein. Nutrition and Cancer 29, 24-28.
200. Zhou J-R, Mukherjee P, Clinton SK & Blackburn GL (1998) Soybean components inhibit the growth of human prostate cancer cell line LNCaP in SCID mice via alteration in cell apoptosis, angiogenesis and proliferation. FASEB Journal 12, A658 Abstr. no. 3822.